###begin article-title 0
###xml 55 71 55 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 55 79 <span type="species:ncbi:83334">Escherichia coli O157:H7</span>
Down-Regulation of Platelet Surface CD47 Expression in Escherichia coli O157:H7 Infection-Induced Thrombocytopenia
###end article-title 0
###begin p 1
Conceived and designed the experiments: CYZ KZ. Performed the experiments: YLG DQL ZB. Analyzed the data: YLG DQL ZB KZ. Contributed reagents/materials/analysis tools: CYZ. Wrote the paper: KZ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 103 119 103 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 103 119 <span type="species:ncbi:562">Escherichia coli</span>
###xml 121 125 <span type="species:ncbi:562">STEC</span>
###xml 163 167 <span type="species:ncbi:562">STEC</span>
Platelet depletion is a key feature of hemolytic uremic syndrome (HUS) caused by Shiga toxin-producing Escherichia coli (STEC) infection. The mechanism underlying STEC-induced platelet depletion, however, is not completely understood.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:562">STEC</span>
###xml 193 197 <span type="species:ncbi:562">STEC</span>
###xml 453 458 <span type="species:ncbi:9606">human</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
Here we demonstrated for the first time that platelet surface expression of CD47 was significantly decreased in C57BL6 mice treated with concentrated culture filtrates (CCF) from STEC O157:H7. STEC O157:H7 CCF treatment also led to a sharp drop of platelet counts. The reduction of cell surface CD47 was specific for platelets but not for neutrophil, monocytes and red blood cells. Down-regulation of platelet surface CD47 was also observed in isolated human platelets treated with O157:H7 CCF. Platelet surface CD47 reduction by O157:H7 CCF could be blocked by anti-TLR4 antibody but not anti-CD62 antibody. Down-regulation of platelet surface CD47 was positively correlated with platelet activation and phagocytosis by human monocyte-derived macrophages. Furthermore, the enhanced phagocytosis process of O157:H7 CCF-treated platelets was abolished by addition of soluble CD47 recombinants.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 91 95 <span type="species:ncbi:562">STEC</span>
Our results suggest that platelet CD47 down-regulation may be a novel mechanism underneath STEC-induced platelet depletion, and that the interactions between CD47 and its receptor, signal regulatory protein alpha (SIRPalpha), play an essential role in modulating platelet homeostasis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 28 44 28 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Karmali1">[1]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Karpman1">[2]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Appiani1">[3]</xref>
###xml 474 477 474 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Katayama1">[4]</xref>
###xml 718 721 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Cohen1">[5]</xref>
###xml 855 858 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Cooling1">[6]</xref>
###xml 1025 1028 1025 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Uchida1">[7]</xref>
###xml 1089 1092 1089 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Obrig1">[8]</xref>
###xml 1094 1097 1094 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Tesh1">[9]</xref>
###xml 1203 1207 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Wadolkowski1">[10]</xref>
###xml 1209 1213 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Karpman2">[11]</xref>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Sauter1">[12]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Taylor1">[13]</xref>
###xml 1244 1248 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Ikeda1">[14]</xref>
###xml 1329 1333 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Rose1">[15]</xref>
###xml 1464 1468 1464 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-teLoo1">[16]</xref>
###xml 1470 1474 1470 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Viisoreanu1">[17]</xref>
###xml 1633 1637 1633 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Nolasco1">[18]</xref>
###xml 1793 1797 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Aslam1">[19]</xref>
###xml 28 44 <span type="species:ncbi:562">Escherichia coli</span>
###xml 46 50 <span type="species:ncbi:562">STEC</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
###xml 1273 1277 <span type="species:ncbi:562">STEC</span>
###xml 1645 1649 <span type="species:ncbi:562">STEC</span>
Shiga toxin (Stx)-producing Escherichia coli (STEC) have been widely reported to be associated with cases of hemolytic uremic syndrome (HUS) [1], [2]. Although thrombocytopenia is a major feature of HUS, the mechanism by which the platelets are depleted in HUS is unclear. Previous studies indicated that platelet activation might be an important factor for thrombocytopenia since expression of platelet-derived products such as platelet factor 4 [3] and soluble P-selectin [4] were elevated during acute HUS. The plasma from patients with HUS also increased aggregation of normal platelets from healthy subjects. As possible causal factor of HUS, Stx1 and Stx2, are representatives of AB class of bacterial exotoxins [5]. For example, Stx can directly bind to human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid [6], and such binding may contribute to platelet activation and microthrombus formation observed in HUS. The toxin has also been identified in the kidney of HUS patients [7] and is cytotoxic for renal endothelial and epithelial cells [8], [9]. Moreover, animal models have reproduced aspects of HUS using wild-type bacteria that produced the toxin [10], [11], [12] or purified toxin [13], [14]. Culture filtrates from STEC were found to induce platelet-aggregating activity [15] although the experiments with purified Shiga toxin showed controversial results in platelet aggregation or P-selection expression [16], [17]. HUS-associated Shiga toxins were found to promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers [18]. Other STEC secreted components such as LPS also play a significant role in developing the aspects of HUS such as platelet activation and thrombocytopenia [19].
###end p 9
###begin p 10
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Lindberg1">[20]</xref>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gardai1">[21]</xref>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Tsai1">[22]</xref>
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Oldenborg1">[23]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gardai1">[21]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Khandelwal1">[24]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Olsson1">[25]</xref>
###xml 548 552 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Yamao1">[26]</xref>
###xml 554 558 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Janssen1">[27]</xref>
###xml 560 564 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Ide1">[28]</xref>
###xml 634 638 <span type="species:ncbi:562">STEC</span>
Serving as an integrin-associated protein and a self-recognition marker [20], [21], [22], [23], CD47 has been implicated in depletion of apoptotic cells and aging cells [21], [24]. Olsson et al [25] previously showed that platelet homeostasis was modulated by platelet CD47 under both normal condition and passive immune thrombocytopenia. The role of interactions between CD47 and its ligand, signal regulatory protein alpha (SIRPalpha), in regulating the clearance of platelets or other apoptotic cells by macrophages was also reported previously [26], [27], [28]. However, the alteration of platelet CD47 expression and its role in STEC infection-induced platelet depletion remains unclear.
###end p 10
###begin p 11
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:562">STEC</span>
In the present study, we demonstrate that platelet surface CD47 expression is specifically reduced in mice treated with concentrated STEC O157:H7-secreted products (CCF) and the effect of O157:H7 CCF is likely toll like receptor (TLR)-dependent. Down-regulation of platelet CD47 is positively correlated with an increase of platelet activation and aggregation, as well as the phagocytosis of platelets by macrophages.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
Bacterial Strains and Reagents
###end title 13
###begin p 14
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gu1">[29]</xref>
###xml 355 371 355 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx1, Stx2, EaeA</italic>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hly</italic>
###xml 422 435 422 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx2-eaeA-hly</italic>
###xml 494 510 494 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx1, Stx2, eaeA</italic>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hly</italic>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Liu1">[30]</xref>
###xml 143 150 <span type="species:ncbi:562">E. coli</span>
###xml 204 208 <span type="species:ncbi:562">STEC</span>
###xml 653 656 <span type="species:ncbi:10116">Rat</span>
###xml 662 667 <span type="species:ncbi:10090">mouse</span>
###xml 766 771 <span type="species:ncbi:9606">human</span>
###xml 852 857 <span type="species:ncbi:10090">mouse</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 924 929 <span type="species:ncbi:10090">Mouse</span>
###xml 935 940 <span type="species:ncbi:9606">Human</span>
EHEC O157:H7 (strain 99G144) was derived from an outbreak of hemolytic-uremic syndrome (HUS) in Xuzhou, Jiangsu, China in 1999. Toxin-negative E. coli O157:H19 (strain 99A041) was used as a control [29]. STEC isolates were serotyped using antisera against E-coli O antigens 1 to 173 and H antigens 15 to 56. PCR results against four major virulence genes Stx1, Stx2, EaeA and Hly have demonstrated that strain 99G144 is a Stx2-eaeA-hly type strain, while strain 99A041 is negative for signs of Stx1, Stx2, eaeA, and hly virulence genes. The Stx production was tested by using the Vero cell cytotoxicity assay and a commercial latex agglutination assay. Rat anti-mouse CD47 affinity purified mAb (clone miap301) was obtained from BD Biosciences (San Diego, CA). Anti-human TLR4 and TLR9 antibodies were obtained from Imgenex (San Diego, CA). Inhibitory mouse anti-human CD47 mAb (C5D5) was used as previously described [30]. Mouse Anti-Human CD61 mAb (Clone Y2/51) was obtained from DAKO (Carpinteria, CA).
###end p 14
###begin title 15
###xml 57 61 <span type="species:ncbi:562">STEC</span>
Preparation of concentrated culture filtrates (CCF) from STEC
###end title 15
###begin p 16
###xml 210 214 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Zhang1">[31]</xref>
###xml 0 4 <span type="species:ncbi:562">STEC</span>
STEC strains were grown overnight in Tryticase soy broth (Difco Laboratories, Detroit, MI) at 37degreesC with shaking (180 rpm), supernatants were filtered through 0.22 microm pore-diameter filters (Millipore) [31], and concentrated to 3-fold higher concentration before used.
###end p 16
###begin title 17
Animal procedure
###end title 17
###begin p 18
###xml 926 929 926 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">Mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
6-8 weeks male C57BL6 mice (Jackson Laboratory, Bar Harbor, ME) were housed with free access to water and food in a specific pathogen-free facility. All animal care and handling procedures were carried out in accordance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals and approved by the Institutional Review Board of Nanjing University, Nanjing, China. Mice were randomly divided into three groups. Group 1 (n = 6) included control mice (1 ml of saline was injected intraperitoneally); in group 2 (n = 8), 1 ml of CCF from O157:H7 (strain 99G144) was administered intraperitoneally on day 1 and day 2; in group 3 (n = 6), 1 ml of CCF from O157:H19 (strain 99A041) was administered on day 1 and day 2. All mice were sacrificed on day 4 after blood and urine sampling. Complete blood count and the measurement of lactic dehydrogenase (LDH) level were performed. CD47 knockout mice (CD47-/-) obtained from Jackson Laboratory served as a control for CD47 measurement.
###end p 18
###begin title 19
Cell isolation and labeling
###end title 19
###begin p 20
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Olsson1">[25]</xref>
###xml 340 341 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 344 345 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 348 349 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 362 363 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 635 636 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 760 761 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1051 1052 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1426 1430 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Liu2">[32]</xref>
###xml 1603 1607 1591 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Poole1">[33]</xref>
###xml 1633 1634 1621 1622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 432 437 <span type="species:ncbi:10090">mouse</span>
###xml 1086 1091 <span type="species:ncbi:9606">Human</span>
###xml 1312 1323 <span type="species:ncbi:9606">participant</span>
###xml 1325 1330 <span type="species:ncbi:9606">Human</span>
Isolation and labeling of platelets were done as previously described [25] with a few modifications. In brief, anticoagulation buffer contained the following: 130 mM trisodium citrate, 10 mMEDTA, 10 mM theophylline, and 2 microg/mL carbacyclin. Buffered saline glucose citrate (BSGC) contained 110 mM NaCl, 14 mM trisodium citrate, 10 mM Na2HPO4-7H2O, 2 mM KH2PO2, 1 mM EDTA, 10 mM glucose, and 1 microg/mL carbacyclin, pH 6.8. For mouse platelets, blood was obtained by cardiac puncture using a syringe containing anticoagulant buffer. The blood was further diluted to a total volume of 1.5 mL in BSGC followed by centrifugation (300 g, 3 min). Platelet-rich plasma (PRP) fractions were collected, combined, and re-suspended in BSGC to a concentration of 5x108 platelets/mL. Isolated cells were identified as platelets by labeling with anti-CD41 phycoerythrin (PE)-conjugated antibody (Immunotech). 2.5 microM CMFDA (Molecular Probes) was added to the platelets and incubated for 30 minutes at room temperature. Platelets were then centrifuged (1200 g, 10 min) to remove the free dye. Human platelets were isolated from periphery blood of healthy volunteers. The present study was approved by the Institutional Review Board of Nanjing University, Nanjing, China. Written informed consent was obtained from each participant. Human monocytes, neutrophils (PMNs) and red blood cells (RBCs) were isolated as previously described [32]. To prepare monocyte-derived macrophages (MDMs), isolated monocytes were cultured in DMEM/10% FCS supplemented with macrophage colony-stimulating factor (M-CSF) for 6 days [33]. Mature macrophages (3x105/well) were then plated in 24-well tissue culture plates and allowed to adhere for 2 h. After removal of non-adherent cells, the cells were then cultured in DMEM/10% FCS without M-CSF for 24 h before use in phagocytosis assays. All the protocols and procedures were approved by Nanjing University Research Ethics Board.
###end p 20
###begin title 21
Immunofluorescence labeling and flow cytometric analysis
###end title 21
###begin p 22
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 113 116 <span type="species:ncbi:10116">rat</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
Blood was collected from a mouse tail vein and was diluted in PBS with 5 mM EDTA. Cells were then incubated with rat anti-CD47 monoclonal antibody (Clone miap301), followed by FITC-conjugated secondary antibody, and phycoerythrin-conjugated anti-mouse CD61 for 30 minutes on ice. After washing off unbound antibody, the samples were analyzed using FACscan flow cytometry and CellQuest software (BD Biosciences). Platelets were distinguished, based on the cell size and CD61 expression.
###end p 22
###begin title 23
Platelet adhesion
###end title 23
###begin p 24
###xml 254 258 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Liu2">[32]</xref>
For platelet adhesion, commercial obtained fibrinogen (FBG) and purified SIRPalpha-GST chimera were immobilized onto 96-well plates prior to adhesion assays. SIRPalpha-GST chimera and GST protein (served as control) were prepared as previously described [32]. Fluorescently labeled platelets were then added into plates and incubated for 1 h at 37degreesC. After three washes, fluorescence intensity of each well was measured by a fluorescence plate reader (Molecular Devise) and cell adhesion was presented as percentage of total applied cells.
###end p 24
###begin title 25
Phagocytosis of platelets by monocyte-derived macrophages
###end title 25
###begin p 26
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 390 391 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Platelets were incubated with anti-platelet CD61 antibody for 20 minutes at room temperature for opsonization. The cells were then washed with HBSS and re-suspended in DMEM/10% FCS. Platelets (3x107/per well) were then added, and the plates were centrifuged at 200 g for 1 min to establish contact between macrophages and platelets. Following incubation for 30 min at 37degreesC under 5% CO2, the macrophages were washed three times with HBSS. To remove non-ingested platelets, the macrophages were treated with 0.5 mM EDTA and 0.05% trypsin in PBS for 5 min. The ingested platelets by macrophages were analyzed by FV1000 confocal fluorescence microscope equipped with software system (Olympus). Percentage of phagocytosis was calculated as the fraction of macrophages with ingested platelets of the total number of macrophages analyzed in 6-8 random selected fields.
###end p 26
###begin title 27
Data analysis
###end title 27
###begin p 28
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 129 130 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis was performed by using Student t test for paired samples. All results are expressed as mean+/-SD. Values of p<0.05 were considered statistically significant.
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 182 198 182 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx1, Stx2, eaeA</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hly</italic>
###xml 242 255 242 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stx2-eaeA-hly</italic>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gu1">[29]</xref>
###xml 644 652 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g001">Figure 1</xref>
###xml 299 303 <span type="species:ncbi:562">STEC</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
###xml 1056 1060 <span type="species:ncbi:562">STEC</span>
In our previous study, an EHEC O157:H7 (strain 99G144) was derived from an outbreak of HUS in Xuzhou, Jiangsu Province, China in 1999. PCR results against four major virulence genes Stx1, Stx2, eaeA and hly have shown that strain 99G144 is a Stx2-eaeA-hly type strain [29]. To assess the ability of STEC O157:H7 (strain 99G144) to induce HUS-like syndrome in animal, we prepared the concentrated culture filtrates (CCF) from culture medium of EHEC strain 99G144 and Shiga toxin-negative O157:H19 (strain 99A041) (served as a control), respectively, and then intraperitoneally injected 0.5 mL/per day of these CCFs into C57BL6 mice. As shown in Figure 1, mice treated with CCF of strain 99G144 had a sharp drop of platelet count on day 4 post-injection compared to mice that injected with saline or strain 99A041 CCF. In addition, significant injure particularly bleeding in multiple organs including kidney, eye and intestine was observed in mice treated with the CCF of strain 99G144 (data not shown). The results implicated that C57BL6 mice treated with STEC O157:H7 CCF suffered a HUS-like symptom.
###end p 30
###begin title 31
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:562">STEC</span>
Platelet depletion in C57BL6 mice administered with concentrated culture filtrates (CCF) of STEC O157:H7 (strain 99G144).
###end title 31
###begin p 32
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Note that platelet number was rapidly decreased in mice treated with O157:H7 (strain 99G144) CCF (n = 8) compared to that in mice treated with saline (n = 6) or CCF from O157:H19 (strain 99A041) (n = 6). *, p<0.05, **, p<0.01.
###end p 32
###begin p 33
###xml 327 336 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g002">Figure 2A</xref>
###xml 525 534 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g002">Figure 2B</xref>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
We next assessed the expression level of CD47 on the surfaces of platelets, neutrophils (PMNs), monocytes, and red blood cells (RBCs), respectively. Surprisingly, we found that, on day 3 post-injection, strain 99G144 CCF treatment strongly decreased CD47 expression on platelet cell surface measured by FACscan flow cytometry (Figure 2A). In contrast, CD47 expression levels on the surfaces of other cell types in mouse circulating blood stream, such as PMNs, monocytes, and RBCs, were not affected by O157:H7 CCF treatment (Figure 2B). Served as a control, treatment with CCF from Shiga toxin-negative O157:H19 (strain 99A041) did not affect platelet surface CD47 expression level.
###end p 33
###begin title 34
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:562">STEC</span>
Reduction of platelet surface CD47 expression in mice treated with CCF from STEC O157:H7 (strain 99G144).
###end title 34
###begin p 35
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:562">STEC</span>
A, CD47 expression on platelet surfaces measured by flow cytometry. Cells derived from CD47-/- mice served as a negative control in CD47 immunofluorescence labeling and measurement by flow cytometry. B, CD47 expression levels on the surfaces of platelets (PLT), neutrophils (PMN), monocytes (MO), and red blood cells (RBC), respectively. Shiga toxin-negative strain 99A041 (O157:H19) was used as a control for STEC O157:H7 (strain 99G144). Data were presented as mean+/-SD of three independent experiments. *, p<0.05.
###end p 35
###begin p 36
###xml 353 354 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 368 377 362 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g003">Figure 3A</xref>
###xml 687 691 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gu1">[29]</xref>
###xml 998 1002 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Aslam1">[19]</xref>
###xml 1012 1016 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Stahl1">[34]</xref>
###xml 1236 1245 1230 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g003">Figure 3B</xref>
###xml 1833 1837 1827 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Zhang2">[35]</xref>
###xml 1922 1931 1916 1925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g003">Figure 3B</xref>
###xml 14 18 <span type="species:ncbi:562">STEC</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 646 650 <span type="species:ncbi:562">STEC</span>
###xml 843 847 <span type="species:ncbi:562">STEC</span>
###xml 1059 1063 <span type="species:ncbi:562">STEC</span>
###xml 1200 1204 <span type="species:ncbi:562">STEC</span>
###xml 1455 1459 <span type="species:ncbi:562">STEC</span>
The effect of STEC O157:H7 CCF on platelet surface CD47 expression was further determined using isolated human platelets. For these experiments, platelets were isolated from periphery blood of healthy donors, washed with HBSS containing EDTA, and then incubated with CCF from O157:H7 (strain 99G144) or O157:H19 (strain 99A041) at 37degreesC under 5% CO2. As shown in Figure 3A, platelet surface CD47 expression was reduced by treatment with strain 99G144 CCF but not strain 99A041 CCF, implicating that the component(s) in strain 99G144 CCF can directly interact with platelets and down-regulate platelet CD47 expression. Based on the fact that STEC strain 99G144 is a Stx2-type strain [29] and we did detect significant amount of stx2 in CCF of strain 99G144 but not strain 99A041 (data not shown), the reduction of platelet surface CD47 by STEC strain 99G144 CCF might be partially due to direct interaction between Stx2 and platelets. Since it has been reported that toll like receptors (TLRs) [19] and CD62 [34] were involved in themocypernia induced by STEC-derived products, we next tested whether TLRs and CD62 play a role in platelet surface CD47 reduction and platelet depletion induced by STEC strain 99G144 CCF. As shown in Figure 3B, functional anti-TLR4 antibody strongly blocked the effects of strain 99G144 CCF on platelet surface CD47 expression while anti-CD62 antibody showed no effect. Antibody against TLR9 also reduced the effect of STEC strain 99G144 CCF on platelet surface CD47 expression, albeit at much lower intensity. The results implicated that TLR4-mediated signal pathway might be involved in the modulation of platelet surface CD47 expression by strain 99G144 CCF treatment. This conclusion was also supported by directly treating platelets with lipopolysaccharide (LPS), a TLR4 activating substance [35]. The platelet surface CD47 expression was significantly decreased by LPS treatment (Figure 3B).
###end p 36
###begin title 37
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 74 78 <span type="species:ncbi:562">STEC</span>
Reduction of CD47 surface expression level on isolated human platelets by STEC O157:H7 (strain 99G144) CCF.
###end title 37
###begin p 38
A, strain 99G144 CCF but not O157:H19 CCF decreases CD47 surface expression. B, Reduction of CD47 expression levels by strain 99G144 CCF in the presence of various antibodies at concentration of 25 microg/ml each. Data were presented as mean+/-SD of three independent experiments. *, p<0.05.
###end p 38
###begin p 39
###xml 427 431 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Yamazaki1">[36]</xref>
###xml 433 437 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Jung1">[37]</xref>
###xml 451 460 443 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g004">Figure 4A</xref>
###xml 954 963 938 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g004">Figure 4B</xref>
###xml 78 82 <span type="species:ncbi:562">STEC</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
To examine the functional status of platelets after treatment with the CCF of STEC O157:H7, isolated human platelets incubated with or without strain 99G144 CCF were further allowed to adhere to 96-well tissue culture plates coated with fibrinogen (FBG) or soluble recombinant of SIRPalpha extracellular domain (SIRPalpha-GST). It has been known when platelets are activated, there are more platelets adhere to immobilized FBG [36], [37]. As shown in Figure 4A, adhesion of platelets treated with strain 99G144 CCF to immobilized FBG was significantly higher than that of non-treated platelets, suggesting that platelets treated with strain 99G144 CCF were activated. These same platelets treated with strain 99G144 CCF, however, showed a decreased adhesion to immobilized SIRPalpha-GST recombinant compared to non-treated platelets, confirming that platelets treated with strain 99G144 CCF have less functional SIRPalpha-binding CD47 on their surfaces (Figure 4B). Together, these results demonstrate that platelets treated with strain 99G144 CCF are in activated form and contain less cell surface CD47.
###end p 39
###begin title 40
Down-regulation of platelet surface CD47 expression level positively correlates with activation of platelets.
###end title 40
###begin p 41
###xml 148 156 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The adhesion of platelets to immobilized fibrinogen (FBG) (A) and SIRPalpha extracellular domain recombinant (SIRPalpha-GST) (B) was measured by an in vitro binding assay. BSA and GST were used as the controls for FBG and SIRPalpha-GST in binding assays, respectively. Data were presented as mean+/-SD of three independent experiments. *, p<0.05.
###end p 41
###begin p 42
###xml 378 386 374 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g005">Figure 5</xref>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 1101 1105 <span type="species:ncbi:562">STEC</span>
We next determined the phagocytosis of platelets treated with or without strain 99G144 CCF by human monocyte-derived macrophages (MDMs). Platelets were treated with anti-platelet IgG for opsonization. In separate experiments, incubation was performed in the presence of inhibitory anti-SIRPalpha antibody or soluble CD47 extracellular domain recombinant (CD47-GST). As shown in Figure 5, after 3 h incubation, phagocytosis of strain 99G144 CCF-treated platelets by MDMs was significantly higher than that of non-treated platelets or platelets treated with strain 99A041 CCF. In fact, internalization of non-treated platelets by MDMs was very low. The enhanced uptake of strain 99G144 CCF-treated platelets by MDMs, however, was abolished by addition of soluble CD47 extracellular domain recombinant. These results argue that down-regulation of CD47 expression level on platelet surfaces is positively correlated with platelet depletion by phagocytes such as macrophages, and that the interactions between platelet CD47 and macrophage SIRPalpha play a critical role in regulating platelet depletion in STEC infection-induced thrombocytopenia.
###end p 42
###begin title 43
###xml 58 63 <span type="species:ncbi:9606">human</span>
Enhanced phagocytosis of O157:H7 CCF-treated platelets by human monocytic-derived macrophages.
###end title 43
###begin p 44
Percentage of phagocytosis was calculated as the fraction of macrophages with ingested platelets of the total number of macrophages analyzed in 6-8 random selected fields per slide. Soluble CD47 extracellular domain recombinant and GST only were added at 40 microg/ml each. Data were presented as mean+/-SD of three independent experiments. *, p<0.05.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 224 232 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1194 1203 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g004">Figure 4A</xref>
###xml 1271 1280 1271 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g004">Figure 4B</xref>
###xml 1549 1555 1549 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007131-g005">Fig. 5</xref>
###xml 134 138 <span type="species:ncbi:562">STEC</span>
###xml 350 354 <span type="species:ncbi:562">STEC</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 573 577 <span type="species:ncbi:562">STEC</span>
###xml 658 662 <span type="species:ncbi:562">STEC</span>
###xml 696 701 <span type="species:ncbi:9606">human</span>
###xml 1008 1012 <span type="species:ncbi:562">STEC</span>
###xml 1134 1138 <span type="species:ncbi:562">STEC</span>
###xml 1148 1152 <span type="species:ncbi:562">STEC</span>
###xml 1339 1343 <span type="species:ncbi:562">STEC</span>
In the present study, we reported for the first time that platelet surface CD47 reduction is a critical step of platelet depletion in STEC-induced HUS. This conclusion was supported by the data derived from both in vivo and in vitro experiments. First, co-occurrence of platelet depletion and down-regulation of platelet surface CD47 was observed in STEC O157:H7 infected mice. Reduction of CD47 expression level was likely specific for platelets since other cells in mouse blood stream had no alteration of surface CD47 after treatment. Second, we confirmed the effect of STEC O157:H7 CCF on reduction of platelet surface CD47 and showed the direct role of STEC strain 99G144 CCF using isolated human platelets. Furthermore, we found that the reduction of platelet surface CD47 expression by strain 99G144 CCF could be blocked by anti-TLRs antibodies, implicating that TLRs-mediated signal downstream might play a significant role in regulating the interactions of platelets with the virulent components of STEC strain 99G144. Third, employing in vitro binding assay, we showed that the platelets treated with secreted products from STEC O157:H7 (STEC strain 99G144) were in active condition (Figure 4A) and contained less functional ligand-binding CD47 on the surface (Figure 4B). Finally, we demonstrated that activated platelets after STEC O157:H7 CCF treatment could be rapidly removed by macrophages through phagocytosis, and that the phagocytosis of platelets by macrophages could be blocked by soluble CD47 extracellular domain recombinant (Fig. 5). These results suggest that the binding interaction between CD47 and its cellular liagnd, signal regulatory protein alpha (SIRPalpha), serves as a critical negative regulator for platelet depletion by phagocytes such as macrophages.
###end p 46
###begin p 47
###xml 56 72 56 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Wadolkowski1">[10]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Karpman2">[11]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Sauter1">[12]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Fernandez1">[38]</xref>
###xml 56 72 <span type="species:ncbi:562">Escherichia coli</span>
###xml 320 324 <span type="species:ncbi:562">STEC</span>
###xml 542 546 <span type="species:ncbi:562">STEC</span>
Previous studies have shown that Shiga toxins producing Escherichia coli are the main cause of the hemolytic uremic syndrome [10], [11], [12], [38]. However, although our data implicated that Shiga toxins might directly interact with platelets and play a role in platelet surface CD47 reduction, the exact components in STEC strain 99G144 CCF that affect platelet CD47 expression remain unclear. Besides Stx2, LPS might also be the candidates in down-regulating platelet cell surface CD47 expression. It also remains unknown why infection by STEC O157:H7 (strain 99G144) selectively reduces platelet surface CD47 expression but not other circulating cells such as monocytes, neutrophils and red blood cells. The possible reason underneath this specific platelet CD47 reduction may be that platelets express unknown receptor(s) for virulent factors such as Stx2 or LPS.
###end p 47
###begin p 48
###xml 420 424 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007131-Gardai1">[21]</xref>
###xml 92 96 <span type="species:ncbi:562">STEC</span>
###xml 218 222 <span type="species:ncbi:562">STEC</span>
###xml 659 663 <span type="species:ncbi:562">STEC</span>
###xml 792 796 <span type="species:ncbi:562">STEC</span>
In summary, our results indicate that CD47 is a critical molecule that negatively regulates STEC-induced activation and depletion of platelets. Down-regulation of CD47 level on platelet surfaces by virulent factors of STEC O157:H7 is likely through TLRs-mediated signaling pathway. CD47 down-regulation on platelet surfaces results in a loss of the negative regulatory mechanism initiated by CD47-SIRPalpha interactions [21], which in turn, leads to platelet activation and consequent phagocytosis of platelets by macrophages or other SIRPalpha-positive immune cells. Since soluble CD47 extracellular domain recombinant can block the enhanced phagocytosis of STEC virulent factors-treated platelets by macrophages, CD47 may be a novel therapeutic targets aiming at attenuating and preventing STEC infection-induced platelet depletion.
###end p 48
###begin p 49
###xml 26 30 <span type="species:ncbi:163112">Ling</span>
We greatly appreciate Dr. Ling Gu (Jiangsu CDC, Nanjing, Jiangsu, China) for providing EHEC O157:H7 (strain 99G144) and Shiga toxin-negative strain (strain 99A041).
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
Infection by verocytotoxin-producing Escherichia coli.
###end article-title 51
###begin article-title 52
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
###end article-title 52
###begin article-title 53
###xml 144 152 <span type="species:ncbi:9606">children</span>
The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
###end article-title 53
###begin article-title 54
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
###end article-title 54
###begin article-title 55
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.
###end article-title 55
###begin article-title 56
###xml 18 23 <span type="species:ncbi:9606">human</span>
Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
###end article-title 56
###begin article-title 57
###xml 49 56 <span type="species:ncbi:9606">patient</span>
The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.
###end article-title 57
###begin article-title 58
###xml 42 47 <span type="species:ncbi:9606">human</span>
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
###end article-title 58
###begin article-title 59
###xml 84 89 <span type="species:ncbi:9606">human</span>
Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
###end article-title 59
###begin article-title 60
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 69 93 <span type="species:ncbi:83334">Escherichia coli O157:H7</span>
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
###end article-title 60
###begin article-title 61
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 72 96 <span type="species:ncbi:83334">Escherichia coli O157:H7</span>
The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection.
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.
###end article-title 62
###begin article-title 63
###xml 24 30 <span type="species:ncbi:9557">baboon</span>
Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.
###end article-title 63
###begin article-title 64
Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.
###end article-title 64
###begin article-title 65
Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome.
###end article-title 65
###begin article-title 66
Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.
###end article-title 66
###begin article-title 67
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human platelet aggregation is not altered by Shiga toxins 1 or 2.
###end article-title 67
###begin article-title 68
Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
###end article-title 68
###begin article-title 69
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.
###end article-title 69
###begin article-title 70
Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding.
###end article-title 70
###begin article-title 71
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.
###end article-title 71
###begin article-title 72
###xml 100 105 <span type="species:ncbi:9606">human</span>
Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells.
###end article-title 72
###begin article-title 73
Role of CD47 as a marker of self on red blood cells [see comments].
###end article-title 73
###begin article-title 74
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation.
###end article-title 74
###begin article-title 75
Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.
###end article-title 75
###begin article-title 76
Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.
###end article-title 76
###begin article-title 77
Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha.
###end article-title 77
###begin article-title 78
Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
###end article-title 78
###begin article-title 79
###xml 31 46 <span type="species:ncbi:83334">E. coli O157:H7</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Heparin blocks the adhesion of E. coli O157:H7 to human colonic epithelial cells.
###end article-title 79
###begin article-title 80
The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47.
###end article-title 80
###begin article-title 81
###xml 96 112 <span type="species:ncbi:562">Escherichia coli</span>
###xml 135 141 <span type="species:ncbi:9606">humans</span>
Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans.
###end article-title 81
###begin article-title 82
Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
###end article-title 82
###begin article-title 83
Repetitive organic dust exposure in vitro impairs macrophage differentiation and function.
###end article-title 83
###begin article-title 84
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.
###end article-title 84
###begin article-title 85
Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
###end article-title 85
###begin article-title 86
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction.
###end article-title 86
###begin article-title 87
Activation of the platelet collagen receptor integrin alpha(2)beta(1): its mechanism and participation in the physiological functions of platelets.
###end article-title 87
###begin article-title 88
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome.
###end article-title 88
###begin p 89
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 89
###begin p 90
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by research grants from Nanjing University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 90

